Cargando…
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) convened a w...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278162/ https://www.ncbi.nlm.nih.gov/pubmed/30514399 http://dx.doi.org/10.1186/s40425-018-0453-4 |